[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![MicrocapTrader Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::75354209.png) Find Alpha [@MicrocapTrader](/creator/twitter/MicrocapTrader) on x 9447 followers
Created: 2025-03-17 19:37:18 UTC

from this AM $FLHLF (🍄): 
FILAMENT HEALTH ANNOUNCES POSITIVE DATA FROM PHASE X STUDY OF PEX010 IN PATIENTS WITH ALCOHOL USE DISORDER
* Open-label study at Psychiatric Centre Copenhagen found that alcohol consumption significantly decreased amongst participants dosed with Filament's botanical psilocybin drug candidate
* After a single dose of PEX010, the mean percentage of heavy drinking days was reduced by more than XX% over the 12-week observation period


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1901719512841683087/c:line.svg)

**Related Topics**
[copenhagen](/topic/copenhagen)
[$flhlf](/topic/$flhlf)

[Post Link](https://x.com/MicrocapTrader/status/1901719512841683087)